The immune system is an assembly of structures and processes inside the body to protect against possibly damaging foreign bodies and diseases. It identifies various threats like bacteria, viruses, and parasites and distinguishes them from body's healthy tissues. When the immune system weakness and lose the capability to detect and destroy the abnormal cells or body attacks and damages its tissues lead to diseases like cancer and autoimmune diseases. Immunotherapy is a process which includes the treatment by inducing, enhancing or suppressing an immune system to fight against the diseases.
Market Analysis and Insights: Global Immunology Drug Market
This report focuses on Global Immunology Drug LBI Global market.
The global Immunology Drug market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026.
Global Immunology Drug Scope and Market Size
Immunology Drug market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Immunology Drug market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2015-2026.
Segment by Type, the Immunology Drug market is segmented into
Monoclonal Antibodies (mAb)
Antibody Drug Conjugates
Interferon and Cytokine therapies
Immunosuppressive medication
Segment by Application, the Immunology Drug market is segmented into
Hospitals
Clinics
Cancer Research Centers and Institutes
Regional and Country-level Analysis
The Immunology Drug market is analysed and market size information is provided by regions (countries).
The key regions covered in the Immunology Drug market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Immunology Drug Market Share Analysis
Immunology Drug market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Immunology Drug business, the date to enter into the Immunology Drug market, Immunology Drug product introduction, recent developments, etc.
The major vendors covered:
Abbott Laboratories
Active Biotech
Eli Lilly and Company
Autoimmune Inc.
Pfizer
GlaxoSmithKline plc
Seattle Genetics
Genentech
F. Hoffmann-La Roche Ltd.
Eisai Co.
Bayer AG
Sanofi Aventis LLC.
Market Analysis and Insights: Global Immunology Drug Market
This report focuses on Global Immunology Drug LBI Global market.
The global Immunology Drug market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026.
Global Immunology Drug Scope and Market Size
Immunology Drug market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Immunology Drug market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2015-2026.
Segment by Type, the Immunology Drug market is segmented into
Monoclonal Antibodies (mAb)
Antibody Drug Conjugates
Interferon and Cytokine therapies
Immunosuppressive medication
Segment by Application, the Immunology Drug market is segmented into
Hospitals
Clinics
Cancer Research Centers and Institutes
Regional and Country-level Analysis
The Immunology Drug market is analysed and market size information is provided by regions (countries).
The key regions covered in the Immunology Drug market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Immunology Drug Market Share Analysis
Immunology Drug market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Immunology Drug business, the date to enter into the Immunology Drug market, Immunology Drug product introduction, recent developments, etc.
The major vendors covered:
Abbott Laboratories
Active Biotech
Eli Lilly and Company
Autoimmune Inc.
Pfizer
GlaxoSmithKline plc
Seattle Genetics
Genentech
F. Hoffmann-La Roche Ltd.
Eisai Co.
Bayer AG
Sanofi Aventis LLC.
1 Study Coverage
1.1 Immunology Drug Product Introduction
1.2 Market Segments
1.3 Key Immunology Drug Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Immunology Drug Market Size Growth Rate by Type
1.4.2 Monoclonal Antibodies (mAb)
1.4.3 Antibody Drug Conjugates
1.4.4 Interferon and Cytokine therapies
1.4.5 Immunosuppressive medication
1.5 Market by Application
1.5.1 Global Immunology Drug Market Size Growth Rate by Application
1.5.2 Hospitals
1.5.3 Clinics
1.5.4 Cancer Research Centers and Institutes
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Immunology Drug Market Size, Estimates and Forecasts
2.1.1 Global Immunology Drug Revenue 2015-2026
2.1.2 Global Immunology Drug Sales 2015-2026
2.2 Global Immunology Drug, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.3 Immunology Drug Historical Market Size by Region (2015-2020)
2.3.1 Global Immunology Drug Retrospective Market Scenario in Sales by Region: 2015-2020
2.3.2 Global Immunology Drug Retrospective Market Scenario in Revenue by Region: 2015-2020
2.4 Immunology Drug Market Estimates and Projections by Region (2021-2026)
2.4.1 Global Immunology Drug Sales Forecast by Region (2021-2026)
2.4.2 Global Immunology Drug Revenue Forecast by Region (2021-2026)
3 Global Immunology Drug Competitor Landscape by Players
3.1 Global Top Immunology Drug Sales by Manufacturers
3.1.1 Global Immunology Drug Sales by Manufacturers (2015-2020)
3.1.2 Global Immunology Drug Sales Market Share by Manufacturers (2015-2020)
3.2 Global Immunology Drug Manufacturers by Revenue
3.2.1 Global Immunology Drug Revenue by Manufacturers (2015-2020)
3.2.2 Global Immunology Drug Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Immunology Drug Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Immunology Drug Revenue in 2019
3.2.5 Global Immunology Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Global Immunology Drug Price by Manufacturers
3.4 Global Immunology Drug Manufacturing Base Distribution, Product Types
3.4.1 Immunology Drug Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Immunology Drug Product Type
3.4.3 Date of International Manufacturers Enter into Immunology Drug Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Immunology Drug Market Size by Type (2015-2020)
4.1.1 Global Immunology Drug Sales by Type (2015-2020)
4.1.2 Global Immunology Drug Revenue by Type (2015-2020)
4.1.3 Immunology Drug Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Immunology Drug Market Size Forecast by Type (2021-2026)
4.2.1 Global Immunology Drug Sales Forecast by Type (2021-2026)
4.2.2 Global Immunology Drug Revenue Forecast by Type (2021-2026)
4.2.3 Immunology Drug Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Immunology Drug Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Immunology Drug Market Size by Application (2015-2020)
5.1.1 Global Immunology Drug Sales by Application (2015-2020)
5.1.2 Global Immunology Drug Revenue by Application (2015-2020)
5.1.3 Immunology Drug Price by Application (2015-2020)
5.2 Immunology Drug Market Size Forecast by Application (2021-2026)
5.2.1 Global Immunology Drug Sales Forecast by Application (2021-2026)
5.2.2 Global Immunology Drug Revenue Forecast by Application (2021-2026)
5.2.3 Global Immunology Drug Price Forecast by Application (2021-2026)
6 United States by Players, Type and Application
6.1 United States Immunology Drug Market Size YoY Growth 2015-2026
6.1.1 United States Immunology Drug Sales YoY Growth 2015-2026
6.1.2 United States Immunology Drug Revenue YoY Growth 2015-2026
6.1.3 United States Immunology Drug Market Share in Global Market 2015-2026
6.2 United States Immunology Drug Market Size by Players (International and Local Players)
6.2.1 United States Top Immunology Drug Players by Sales (2015-2020)
6.2.2 United States Top Immunology Drug Players by Revenue (2015-2020)
6.3 United States Immunology Drug Historic Market Review by Type (2015-2020)
6.3.1 United States Immunology Drug Sales Market Share by Type (2015-2020)
6.3.2 United States Immunology Drug Revenue Market Share by Type (2015-2020)
6.3.3 United States Immunology Drug Price by Type (2015-2020)
6.4 United States Immunology Drug Market Estimates and Forecasts by Type (2021-2026)
6.4.1 United States Immunology Drug Sales Forecast by Type (2021-2026)
6.4.2 United States Immunology Drug Revenue Forecast by Type (2021-2026)
6.4.3 United States Immunology Drug Price Forecast by Type (2021-2026)
6.5 United States Immunology Drug Historic Market Review by Application (2015-2020)
6.5.1 United States Immunology Drug Sales Market Share by Application (2015-2020)
6.5.2 United States Immunology Drug Revenue Market Share by Application (2015-2020)
6.5.3 United States Immunology Drug Price by Application (2015-2020)
6.6 United States Immunology Drug Market Estimates and Forecasts by Application (2021-2026)
6.6.1 United States Immunology Drug Sales Forecast by Application (2021-2026)
6.6.2 United States Immunology Drug Revenue Forecast by Application (2021-2026)
6.6.3 United States Immunology Drug Price Forecast by Application (2021-2026)
7 North America
7.1 North America Immunology Drug Market Size YoY Growth 2015-2026
7.2 North America Immunology Drug Market Facts & Figures by Country
7.2.1 North America Immunology Drug Sales by Country (2015-2020)
7.2.2 North America Immunology Drug Revenue by Country (2015-2020)
7.2.3 U.S.
7.2.4 Canada
8 Europe
8.1 Europe Immunology Drug Market Size YoY Growth 2015-2026
8.2 Europe Immunology Drug Market Facts & Figures by Country
8.2.1 Europe Immunology Drug Sales by Country
8.2.2 Europe Immunology Drug Revenue by Country
8.2.3 Germany
8.2.4 France
8.2.5 U.K.
8.2.6 Italy
8.2.7 Russia
9 Asia Pacific
9.1 Asia Pacific Immunology Drug Market Size YoY Growth 2015-2026
9.2 Asia Pacific Immunology Drug Market Facts & Figures by Country
9.2.1 Asia Pacific Immunology Drug Sales by Region (2015-2020)
9.2.2 Asia Pacific Immunology Drug Revenue by Region
9.2.3 China
9.2.4 Japan
9.2.5 South Korea
9.2.6 India
9.2.7 Australia
9.2.8 Taiwan
9.2.9 Indonesia
9.2.10 Thailand
9.2.11 Malaysia
9.2.12 Philippines
9.2.13 Vietnam
10 Latin America
10.1 Latin America Immunology Drug Market Size YoY Growth 2015-2026
10.2 Latin America Immunology Drug Market Facts & Figures by Country
10.2.1 Latin America Immunology Drug Sales by Country
10.2.2 Latin America Immunology Drug Revenue by Country
10.2.3 Mexico
10.2.4 Brazil
10.2.5 Argentina
11 Middle East and Africa
11.1 Middle East and Africa Immunology Drug Market Size YoY Growth 2015-2026
11.2 Middle East and Africa Immunology Drug Market Facts & Figures by Country
11.2.1 Middle East and Africa Immunology Drug Sales by Country
11.2.2 Middle East and Africa Immunology Drug Revenue by Country
11.2.3 Turkey
11.2.4 Saudi Arabia
11.2.5 U.A.E
12 Company Profiles
12.1 Abbott Laboratories
12.1.1 Abbott Laboratories Corporation Information
12.1.2 Abbott Laboratories Description and Business Overview
12.1.3 Abbott Laboratories Sales, Revenue and Gross Margin (2015-2020)
12.1.4 Abbott Laboratories Immunology Drug Products Offered
12.1.5 Abbott Laboratories Recent Development
12.2 Active Biotech
12.2.1 Active Biotech Corporation Information
12.2.2 Active Biotech Description and Business Overview
12.2.3 Active Biotech Sales, Revenue and Gross Margin (2015-2020)
12.2.4 Active Biotech Immunology Drug Products Offered
12.2.5 Active Biotech Recent Development
12.3 Eli Lilly and Company
12.3.1 Eli Lilly and Company Corporation Information
12.3.2 Eli Lilly and Company Description and Business Overview
12.3.3 Eli Lilly and Company Sales, Revenue and Gross Margin (2015-2020)
12.3.4 Eli Lilly and Company Immunology Drug Products Offered
12.3.5 Eli Lilly and Company Recent Development
12.4 Autoimmune Inc.
12.4.1 Autoimmune Inc. Corporation Information
12.4.2 Autoimmune Inc. Description and Business Overview
12.4.3 Autoimmune Inc. Sales, Revenue and Gross Margin (2015-2020)
12.4.4 Autoimmune Inc. Immunology Drug Products Offered
12.4.5 Autoimmune Inc. Recent Development
12.5 Pfizer
12.5.1 Pfizer Corporation Information
12.5.2 Pfizer Description and Business Overview
12.5.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)
12.5.4 Pfizer Immunology Drug Products Offered
12.5.5 Pfizer Recent Development
12.6 GlaxoSmithKline plc
12.6.1 GlaxoSmithKline plc Corporation Information
12.6.2 GlaxoSmithKline plc Description and Business Overview
12.6.3 GlaxoSmithKline plc Sales, Revenue and Gross Margin (2015-2020)
12.6.4 GlaxoSmithKline plc Immunology Drug Products Offered
12.6.5 GlaxoSmithKline plc Recent Development
12.7 Seattle Genetics
12.7.1 Seattle Genetics Corporation Information
12.7.2 Seattle Genetics Description and Business Overview
12.7.3 Seattle Genetics Sales, Revenue and Gross Margin (2015-2020)
12.7.4 Seattle Genetics Immunology Drug Products Offered
12.7.5 Seattle Genetics Recent Development
12.8 Genentech
12.8.1 Genentech Corporation Information
12.8.2 Genentech Description and Business Overview
12.8.3 Genentech Sales, Revenue and Gross Margin (2015-2020)
12.8.4 Genentech Immunology Drug Products Offered
12.8.5 Genentech Recent Development
12.9 F. Hoffmann-La Roche Ltd.
12.9.1 F. Hoffmann-La Roche Ltd. Corporation Information
12.9.2 F. Hoffmann-La Roche Ltd. Description and Business Overview
12.9.3 F. Hoffmann-La Roche Ltd. Sales, Revenue and Gross Margin (2015-2020)
12.9.4 F. Hoffmann-La Roche Ltd. Immunology Drug Products Offered
12.9.5 F. Hoffmann-La Roche Ltd. Recent Development
12.10 Eisai Co.
12.10.1 Eisai Co. Corporation Information
12.10.2 Eisai Co. Description and Business Overview
12.10.3 Eisai Co. Sales, Revenue and Gross Margin (2015-2020)
12.10.4 Eisai Co. Immunology Drug Products Offered
12.10.5 Eisai Co. Recent Development
12.11 Abbott Laboratories
12.11.1 Abbott Laboratories Corporation Information
12.11.2 Abbott Laboratories Description and Business Overview
12.11.3 Abbott Laboratories Sales, Revenue and Gross Margin (2015-2020)
12.11.4 Abbott Laboratories Immunology Drug Products Offered
12.11.5 Abbott Laboratories Recent Development
12.12 Sanofi Aventis LLC.
12.12.1 Sanofi Aventis LLC. Corporation Information
12.12.2 Sanofi Aventis LLC. Description and Business Overview
12.12.3 Sanofi Aventis LLC. Sales, Revenue and Gross Margin (2015-2020)
12.12.4 Sanofi Aventis LLC. Products Offered
12.12.5 Sanofi Aventis LLC. Recent Development
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Immunology Drug Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Immunology Drug Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
1.1 Immunology Drug Product Introduction
1.2 Market Segments
1.3 Key Immunology Drug Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Immunology Drug Market Size Growth Rate by Type
1.4.2 Monoclonal Antibodies (mAb)
1.4.3 Antibody Drug Conjugates
1.4.4 Interferon and Cytokine therapies
1.4.5 Immunosuppressive medication
1.5 Market by Application
1.5.1 Global Immunology Drug Market Size Growth Rate by Application
1.5.2 Hospitals
1.5.3 Clinics
1.5.4 Cancer Research Centers and Institutes
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Immunology Drug Market Size, Estimates and Forecasts
2.1.1 Global Immunology Drug Revenue 2015-2026
2.1.2 Global Immunology Drug Sales 2015-2026
2.2 Global Immunology Drug, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.3 Immunology Drug Historical Market Size by Region (2015-2020)
2.3.1 Global Immunology Drug Retrospective Market Scenario in Sales by Region: 2015-2020
2.3.2 Global Immunology Drug Retrospective Market Scenario in Revenue by Region: 2015-2020
2.4 Immunology Drug Market Estimates and Projections by Region (2021-2026)
2.4.1 Global Immunology Drug Sales Forecast by Region (2021-2026)
2.4.2 Global Immunology Drug Revenue Forecast by Region (2021-2026)
3 Global Immunology Drug Competitor Landscape by Players
3.1 Global Top Immunology Drug Sales by Manufacturers
3.1.1 Global Immunology Drug Sales by Manufacturers (2015-2020)
3.1.2 Global Immunology Drug Sales Market Share by Manufacturers (2015-2020)
3.2 Global Immunology Drug Manufacturers by Revenue
3.2.1 Global Immunology Drug Revenue by Manufacturers (2015-2020)
3.2.2 Global Immunology Drug Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Immunology Drug Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Immunology Drug Revenue in 2019
3.2.5 Global Immunology Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Global Immunology Drug Price by Manufacturers
3.4 Global Immunology Drug Manufacturing Base Distribution, Product Types
3.4.1 Immunology Drug Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Immunology Drug Product Type
3.4.3 Date of International Manufacturers Enter into Immunology Drug Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Immunology Drug Market Size by Type (2015-2020)
4.1.1 Global Immunology Drug Sales by Type (2015-2020)
4.1.2 Global Immunology Drug Revenue by Type (2015-2020)
4.1.3 Immunology Drug Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Immunology Drug Market Size Forecast by Type (2021-2026)
4.2.1 Global Immunology Drug Sales Forecast by Type (2021-2026)
4.2.2 Global Immunology Drug Revenue Forecast by Type (2021-2026)
4.2.3 Immunology Drug Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Immunology Drug Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Immunology Drug Market Size by Application (2015-2020)
5.1.1 Global Immunology Drug Sales by Application (2015-2020)
5.1.2 Global Immunology Drug Revenue by Application (2015-2020)
5.1.3 Immunology Drug Price by Application (2015-2020)
5.2 Immunology Drug Market Size Forecast by Application (2021-2026)
5.2.1 Global Immunology Drug Sales Forecast by Application (2021-2026)
5.2.2 Global Immunology Drug Revenue Forecast by Application (2021-2026)
5.2.3 Global Immunology Drug Price Forecast by Application (2021-2026)
6 United States by Players, Type and Application
6.1 United States Immunology Drug Market Size YoY Growth 2015-2026
6.1.1 United States Immunology Drug Sales YoY Growth 2015-2026
6.1.2 United States Immunology Drug Revenue YoY Growth 2015-2026
6.1.3 United States Immunology Drug Market Share in Global Market 2015-2026
6.2 United States Immunology Drug Market Size by Players (International and Local Players)
6.2.1 United States Top Immunology Drug Players by Sales (2015-2020)
6.2.2 United States Top Immunology Drug Players by Revenue (2015-2020)
6.3 United States Immunology Drug Historic Market Review by Type (2015-2020)
6.3.1 United States Immunology Drug Sales Market Share by Type (2015-2020)
6.3.2 United States Immunology Drug Revenue Market Share by Type (2015-2020)
6.3.3 United States Immunology Drug Price by Type (2015-2020)
6.4 United States Immunology Drug Market Estimates and Forecasts by Type (2021-2026)
6.4.1 United States Immunology Drug Sales Forecast by Type (2021-2026)
6.4.2 United States Immunology Drug Revenue Forecast by Type (2021-2026)
6.4.3 United States Immunology Drug Price Forecast by Type (2021-2026)
6.5 United States Immunology Drug Historic Market Review by Application (2015-2020)
6.5.1 United States Immunology Drug Sales Market Share by Application (2015-2020)
6.5.2 United States Immunology Drug Revenue Market Share by Application (2015-2020)
6.5.3 United States Immunology Drug Price by Application (2015-2020)
6.6 United States Immunology Drug Market Estimates and Forecasts by Application (2021-2026)
6.6.1 United States Immunology Drug Sales Forecast by Application (2021-2026)
6.6.2 United States Immunology Drug Revenue Forecast by Application (2021-2026)
6.6.3 United States Immunology Drug Price Forecast by Application (2021-2026)
7 North America
7.1 North America Immunology Drug Market Size YoY Growth 2015-2026
7.2 North America Immunology Drug Market Facts & Figures by Country
7.2.1 North America Immunology Drug Sales by Country (2015-2020)
7.2.2 North America Immunology Drug Revenue by Country (2015-2020)
7.2.3 U.S.
7.2.4 Canada
8 Europe
8.1 Europe Immunology Drug Market Size YoY Growth 2015-2026
8.2 Europe Immunology Drug Market Facts & Figures by Country
8.2.1 Europe Immunology Drug Sales by Country
8.2.2 Europe Immunology Drug Revenue by Country
8.2.3 Germany
8.2.4 France
8.2.5 U.K.
8.2.6 Italy
8.2.7 Russia
9 Asia Pacific
9.1 Asia Pacific Immunology Drug Market Size YoY Growth 2015-2026
9.2 Asia Pacific Immunology Drug Market Facts & Figures by Country
9.2.1 Asia Pacific Immunology Drug Sales by Region (2015-2020)
9.2.2 Asia Pacific Immunology Drug Revenue by Region
9.2.3 China
9.2.4 Japan
9.2.5 South Korea
9.2.6 India
9.2.7 Australia
9.2.8 Taiwan
9.2.9 Indonesia
9.2.10 Thailand
9.2.11 Malaysia
9.2.12 Philippines
9.2.13 Vietnam
10 Latin America
10.1 Latin America Immunology Drug Market Size YoY Growth 2015-2026
10.2 Latin America Immunology Drug Market Facts & Figures by Country
10.2.1 Latin America Immunology Drug Sales by Country
10.2.2 Latin America Immunology Drug Revenue by Country
10.2.3 Mexico
10.2.4 Brazil
10.2.5 Argentina
11 Middle East and Africa
11.1 Middle East and Africa Immunology Drug Market Size YoY Growth 2015-2026
11.2 Middle East and Africa Immunology Drug Market Facts & Figures by Country
11.2.1 Middle East and Africa Immunology Drug Sales by Country
11.2.2 Middle East and Africa Immunology Drug Revenue by Country
11.2.3 Turkey
11.2.4 Saudi Arabia
11.2.5 U.A.E
12 Company Profiles
12.1 Abbott Laboratories
12.1.1 Abbott Laboratories Corporation Information
12.1.2 Abbott Laboratories Description and Business Overview
12.1.3 Abbott Laboratories Sales, Revenue and Gross Margin (2015-2020)
12.1.4 Abbott Laboratories Immunology Drug Products Offered
12.1.5 Abbott Laboratories Recent Development
12.2 Active Biotech
12.2.1 Active Biotech Corporation Information
12.2.2 Active Biotech Description and Business Overview
12.2.3 Active Biotech Sales, Revenue and Gross Margin (2015-2020)
12.2.4 Active Biotech Immunology Drug Products Offered
12.2.5 Active Biotech Recent Development
12.3 Eli Lilly and Company
12.3.1 Eli Lilly and Company Corporation Information
12.3.2 Eli Lilly and Company Description and Business Overview
12.3.3 Eli Lilly and Company Sales, Revenue and Gross Margin (2015-2020)
12.3.4 Eli Lilly and Company Immunology Drug Products Offered
12.3.5 Eli Lilly and Company Recent Development
12.4 Autoimmune Inc.
12.4.1 Autoimmune Inc. Corporation Information
12.4.2 Autoimmune Inc. Description and Business Overview
12.4.3 Autoimmune Inc. Sales, Revenue and Gross Margin (2015-2020)
12.4.4 Autoimmune Inc. Immunology Drug Products Offered
12.4.5 Autoimmune Inc. Recent Development
12.5 Pfizer
12.5.1 Pfizer Corporation Information
12.5.2 Pfizer Description and Business Overview
12.5.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)
12.5.4 Pfizer Immunology Drug Products Offered
12.5.5 Pfizer Recent Development
12.6 GlaxoSmithKline plc
12.6.1 GlaxoSmithKline plc Corporation Information
12.6.2 GlaxoSmithKline plc Description and Business Overview
12.6.3 GlaxoSmithKline plc Sales, Revenue and Gross Margin (2015-2020)
12.6.4 GlaxoSmithKline plc Immunology Drug Products Offered
12.6.5 GlaxoSmithKline plc Recent Development
12.7 Seattle Genetics
12.7.1 Seattle Genetics Corporation Information
12.7.2 Seattle Genetics Description and Business Overview
12.7.3 Seattle Genetics Sales, Revenue and Gross Margin (2015-2020)
12.7.4 Seattle Genetics Immunology Drug Products Offered
12.7.5 Seattle Genetics Recent Development
12.8 Genentech
12.8.1 Genentech Corporation Information
12.8.2 Genentech Description and Business Overview
12.8.3 Genentech Sales, Revenue and Gross Margin (2015-2020)
12.8.4 Genentech Immunology Drug Products Offered
12.8.5 Genentech Recent Development
12.9 F. Hoffmann-La Roche Ltd.
12.9.1 F. Hoffmann-La Roche Ltd. Corporation Information
12.9.2 F. Hoffmann-La Roche Ltd. Description and Business Overview
12.9.3 F. Hoffmann-La Roche Ltd. Sales, Revenue and Gross Margin (2015-2020)
12.9.4 F. Hoffmann-La Roche Ltd. Immunology Drug Products Offered
12.9.5 F. Hoffmann-La Roche Ltd. Recent Development
12.10 Eisai Co.
12.10.1 Eisai Co. Corporation Information
12.10.2 Eisai Co. Description and Business Overview
12.10.3 Eisai Co. Sales, Revenue and Gross Margin (2015-2020)
12.10.4 Eisai Co. Immunology Drug Products Offered
12.10.5 Eisai Co. Recent Development
12.11 Abbott Laboratories
12.11.1 Abbott Laboratories Corporation Information
12.11.2 Abbott Laboratories Description and Business Overview
12.11.3 Abbott Laboratories Sales, Revenue and Gross Margin (2015-2020)
12.11.4 Abbott Laboratories Immunology Drug Products Offered
12.11.5 Abbott Laboratories Recent Development
12.12 Sanofi Aventis LLC.
12.12.1 Sanofi Aventis LLC. Corporation Information
12.12.2 Sanofi Aventis LLC. Description and Business Overview
12.12.3 Sanofi Aventis LLC. Sales, Revenue and Gross Margin (2015-2020)
12.12.4 Sanofi Aventis LLC. Products Offered
12.12.5 Sanofi Aventis LLC. Recent Development
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Immunology Drug Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Immunology Drug Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
